Vanguard Group’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,922,809
Closed -$1.59M 4307
2025
Q1
$1.59M Hold
1,922,809
﹤0.01% 3567
2024
Q4
$1.83M Hold
1,922,809
﹤0.01% 3587
2024
Q3
$1.92M Hold
1,922,809
﹤0.01% 3568
2024
Q2
$2.38M Sell
1,922,809
-25,786
-1% -$32K ﹤0.01% 3500
2024
Q1
$2.53M Buy
1,948,595
+247,918
+15% +$322K ﹤0.01% 3516
2023
Q4
$2.13M Buy
1,700,677
+12,312
+0.7% +$15.4K ﹤0.01% 3583
2023
Q3
$2.19M Buy
1,688,365
+89,000
+6% +$116K ﹤0.01% 3550
2023
Q2
$2.75M Buy
1,599,365
+96,549
+6% +$166K ﹤0.01% 3562
2023
Q1
$2.19M Sell
1,502,816
-2,106
-0.1% -$3.08K ﹤0.01% 3636
2022
Q4
$2.44M Buy
1,504,922
+2,338
+0.2% +$3.79K ﹤0.01% 3594
2022
Q3
$5.03M Sell
1,502,584
-307,087
-17% -$1.03M ﹤0.01% 3327
2022
Q2
$6.59M Sell
1,809,671
-791,820
-30% -$2.88M ﹤0.01% 3223
2022
Q1
$18.8M Sell
2,601,491
-790,825
-23% -$5.72M ﹤0.01% 2813
2021
Q4
$46.1M Buy
3,392,316
+58,595
+2% +$796K ﹤0.01% 2397
2021
Q3
$69.9M Buy
3,333,721
+373,518
+13% +$7.83M ﹤0.01% 2177
2021
Q2
$70.9M Buy
2,960,203
+1,502,911
+103% +$36M ﹤0.01% 2183
2021
Q1
$42.7M Buy
1,457,292
+38,005
+3% +$1.11M ﹤0.01% 2402
2020
Q4
$42.4M Buy
+1,419,287
New +$42.4M ﹤0.01% 2286